DRUG SURVIVAL AND CLINICAL EFFICACY OF 7 YEARS ETANERCEPT TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE GLAS COHORT

被引：1
|
作者：
Arends, S. [1 ,2 ]
Brouwer, E. [1 ]
Wink, F. [2 ]
Bos, R. [2 ]
Maas, F. [1 ]
Bootsma, H. [1 ]
van der Veer, E. [3 ]
Spoorenberg, A. [1 ,2 ]
机构：
[1] Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen, Netherlands
[2] Med Ctr Leeuwarden, Rheumatol, Leeuwarden, Netherlands
[3] Univ Med Ctr Groningen, Lab Med, Groningen, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4990
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0239
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [31] Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry
    Ji-Won Kim
    Eunyoung A. Lee
    Hyoun-Ah Kim
    Chang-Hee Suh
    Ju-Yang Jung
    BioDrugs, 2022, 36 : 411 - 419
  • [32] Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry
    Kim, Ji-Won
    Lee, Eunyoung A.
    Kim, Hyoun-Ah
    Suh, Chang-Hee
    Jung, Ju-Yang
    BIODRUGS, 2022, 36 (03) : 411 - 419
  • [33] Ongoing clinical effectiveness and safety in patients with active ankylosing Spondylitis after 4-year treatment with Etanercept
    Baraliakos, X.
    Listing, J.
    Song, H.
    Haibel, H.
    Rudwaleit, M.
    Sieper, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 50 - 50
  • [34] The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: A multicenter controlled clinical trial
    BatlleGualda, E
    Figueroa, M
    Ivorra, J
    Raber, A
    Alegre, AJ
    Alonso, A
    Carbonell, J
    Cruz, J
    Ferreiro, JL
    Ferrer, M
    Garcia, A
    Garcia, S
    Gijon, J
    GomezReino, J
    Jimenez, F
    Laffon, A
    Olmedo, J
    Paulino, J
    PerezBusquier, M
    RodriguezValverde, V
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (07) : 1200 - 1206
  • [35] Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
    Baraliakos, Xenofon
    Haibel, Hildrun
    Fritz, Claudia
    Listing, Joachim
    Heldmann, Frank
    Braun, Juergen
    Sieper, Joachim
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (03)
  • [36] Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
    Xenofon Baraliakos
    Hildrun Haibel
    Claudia Fritz
    Joachim Listing
    Frank Heldmann
    Juergen Braun
    Joachim Sieper
    Arthritis Research & Therapy, 15
  • [37] Adalimumab treatment maintains efficacy and safety in patients with ankylosing spondylitis (AS)-2-year results from ATLAS
    van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 412 - 412
  • [38] Radiographic results from a long-term multicenter trial of etanercept ENBREL®) in patients with Ankylosing Spondylitis.
    Dijkmans, B
    Wanders, A
    van der Heijde, D
    Fatenejad, S
    Afdeling, R
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S634 - S634
  • [39] SUSTAINED AND SIMILAR CLINICAL RESPONSE TO ETANERCEPT AFTER 6 YEARS OF TREATMENT IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND ANKYLOSING SPONDYLITIS: LONG-TERM RESULTS OF THE ESTHER TRIAL
    Poddubnyy, D.
    Song, I. -H.
    Hermann, K. -G.
    Haibel, H.
    Callhoff, J.
    Listing, J.
    Buss, B.
    Freundlich, B.
    Lange, E.
    Rudwaleit, M.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 267 - +
  • [40] Outcome of patients with active ankylosing spondylitis after 2 years of therapy with etanercept - Clinical data supported by magnetic resonance imaging
    Baraliakos, X
    Rudwaleit, M
    Listing, J
    Brandt, J
    Haibel, H
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S632 - S633
12345